Leprosy registered prevalence rate per 1 000 000 population in Norway
Norway: Leprosy registered prevalence rate per 1 000 000 population was 0 in 2024. ◆ Volatile
Latest (2024)
0
World rank
121st
of 169 countries
All-time high
0.18
in 2022
All-time low
0
in 2017
Years of data
6
2017–2024
Leprosy registered prevalence rate per 1 000 000 population in Norway, 2017–2024
Source: World Health Organization, Global Health Observatory.
Analysis
In 2024, leprosy registered prevalence rate per 1 000 000 population in Norway stood at 0. That is the lowest value across all 6 years on record.
Norway ranks 121st of 169 countries on this measure, in the middle of the range.
Leprosy registered prevalence rate per 1 000 000 population in Norway, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 0 | — |
| 2019 | 0 | — |
| 2020 | 0 | — |
| 2022 | 0.18 | — |
| 2023 | 0 | -100.0% |
| 2024 | 0 | — |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 0 | 0 | 0 | 2 |
| 2020s | 0.045 | 0 | 0.18 | 4 |
Countries ranked near Norway
- 118 Uzbekistan 0.083 compare
- 119 Canada 0.075 compare
- 120 Germany 0.012 compare
- 121 Mongolia 0
- 121 Estonia 0
- 121 Finland 0
- 121 Slovenia 0
- 121 Bulgaria 0
- 121 Bosnia and Herzegovina 0
- 121 Seychelles 0 compare
- 121 Grenada 0 compare
- 121 Cook Islands 0
- 121 Netherlands 0 compare
- 121 Syria 0 compare
- 121 San Marino 0
- 121 Bahamas 0 compare
- 121 Nauru 0 compare
- 121 Monaco 0
- 121 Romania 0 compare
- 121 Jordan 0
- 121 North Korea 0
- 121 Brunei 0 compare
- 121 Sweden 0
- 121 Armenia 0
- 121 Sao Tome and Principe 0 compare
- 121 Belgium 0 compare
- 121 Iceland 0
- 121 Belize 0 compare
- 121 Honduras 0 compare
- 121 Kazakhstan 0 compare
- 121 Latvia 0
- 121 Slovakia 0
- 121 Antigua and Barbuda 0
- 121 Lebanon 0 compare
- 121 Dominica 0
- 121 Algeria 0
- 121 Luxembourg 0
- 121 Cyprus 0
- 121 United Arab Emirates 0 compare
- 121 Niue 0
- 121 Saint Vincent and the Grenadines 0 compare
- 121 Tonga 0 compare
- 121 Austria 0
- 121 Georgia 0
- 121 Saint Kitts and Nevis 0
- 121 Lithuania 0
- 121 Belarus 0
- 121 Barbados 0 compare
- 121 Andorra 0 compare
- 121 Malta 0
- 121 Croatia 0
More health data for Norway
- Un projection of annual infant deaths, annual growth rate -7.69 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.337 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,212 deaths per 1,000 people (2090)
- Number of infants who die before age 1 12 deaths (2100)
- Population ages 0-14, female, annual growth rate -0.9506 % change on previous year (2025)
- Population ages 0-14, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 0-14, female, per capita 0.0775 units per person (2025)
- Population ages 0-14, male, annual growth rate -0.9586 % change on previous year (2025)
- Population ages 0-14, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 0-14, male, per capita 0.0817 units per person (2025)
Frequently asked questions
- What is leprosy registered prevalence rate per 1 000 000 population in Norway?
- Leprosy registered prevalence rate per 1 000 000 population in Norway was 0 in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest leprosy registered prevalence rate per 1 000 000 population recorded in Norway?
- The highest recorded value was 0.18 in 2022.
- What is the lowest leprosy registered prevalence rate per 1 000 000 population recorded in Norway?
- The lowest recorded value was 0 in 2017.
- How does Norway rank for leprosy registered prevalence rate per 1 000 000 population?
- Norway ranks 121st out of 169 countries with data for 2024.
- Where does this Norway data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Leprosy registered prevalence rate per 1 000 000 population. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).